AmpliPhi Biosciences Corporation   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Richmond VA United States (1989)
Status: Acquired by C3J Therapeutics (2019)

Organization Overview

First Clinical Trial
2003
NCT00073463
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Mergers & Acquisitions

Historical Acquisition Tree